Navigation Links
Riverside First to Offer New Treatment for Peripheral Arterial Disease

GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface Offers Safe,

Effective Alternative to Surgery

COLUMBUS, Ohio, Sept. 7 /PRNewswire/ -- Gary Ansel, MD, of Riverside Methodist Hospital became the world's first physician on Wednesday, Aug. 29, to treat a common form of peripheral arterial disease (PAD) with a new device that improves outcomes, speeds recovery and may minimize the risk of complications.

Ansel successfully implanted the GORE VIABAHN Endoprosthesis with Heparin Bioactive Surface, a stent graft designed to open blockages in the superficial femoral artery in the thigh, into William Doup, 69, of Bellefontaine, Ohio.

"This is a whole different approach to the problem," said Ansel, an interventional cardiologist at the McConnell Heart Hospital at Riverside. "It may change everything we do."

Eight to 12 million Americans ages 50 and older have PAD, characterized by clogged arterial walls in the legs. These blockages are the same as those found in the heart and neck and can result in death from stroke and heart attack.

A blockage from plaque build-up in the thigh's large superficial femoral artery "is one of the most common types of PAD," Ansel said. "It affects up to 10 percent of the population over the age of 70."

Stents are small, metal coil or mesh tubes commonly inserted into arteries to reduce vessel narrowing and improve circulation.

The device is made by W.L. Gore & Associates in Flagstaff, Arizona, a company known for its consumer product Gore-Tex. "It's the same material that's in my rain suit for golf," said Doup, the pioneering patient.

The U.S. Food and Drug Administration approved its use in August to relieve hardening of the thigh artery.

The cloth combines mechanical and a pharmacologic approach to opening leg blockage. The Gore-Tex fabric stops tissue from growing inside the tube and has the blood thinning medication Heparin as part of the device lining.

The Gore-Tex keeps the Heparin anchored to its surface, allowing the medication to interact with the blood for years. "It's like putting a stain retardant covering on furniture," Ansel said.

The stent placement is a less invasive alternative to bypass surgery that requires an incision or several incisions over the entire length of the thigh with a four- to six-week recovery.

"Many patients had to undergo bypass surgery to treat these blockages. Now we can treat the same population non-surgically," Ansel said. "Safety goes with the fact that this is less invasive. For example, the chance of infection goes down from 20 to 1/2 percent."

Ansel inserted the device in Doup's leg in 20 minutes through a puncture the size of a ballpoint pen tip.

"I checked in for the procedure at 6 a.m. and went home the same day at 12:45 p.m.," Doup said.

He expects to return to work and his beloved golf one week later.

"I've been telling everybody that I'm a star," Doup said. "I love being a part of a medical breakthrough."

Riverside is one of the nation's top centers for the treatment of peripheral arterial disease, performing more than 2,000 procedures a year.

"As the population ages, we are seeing dramatic increases in PAD," Ansel said. "It's often a disease among people who eat the wrong things and don't exercise. For the foreseeable future, it looks like nothing better is going to replace this Gore stent" -- the only FDA-approved stent graft for the superficial femoral artery.

Riverside Methodist Hospital

Riverside Methodist Hospital is a member of OhioHealth, a nationally recognized, not-for-profit, charitable, healthcare organization serving and supporting the community. It was named by FORTUNE magazine as one of the "100 Best Companies To Work For in 2007." Based in Columbus, Ohio, OhioHealth is a family of 15 hospitals, 20 health and surgery centers, home-health providers, medical equipment and health service suppliers throughout a 46-county area. OhioHealth Hospitals in central Ohio are Riverside Methodist Hospital, Grant Medical Center, Doctors Hospital, Grady Memorial Hospital and Dublin Methodist Hospital (to open Jan. 8, 2008). For more information, please visit our Web site at .

SOURCE Riverside Methodist Hospital
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First Vaccine Designed for Africa Cleared for Testing in Humans
2. Infant receives first bloodless liver transplant
3. Oracle Corp. to help build worlds first "Digital Hospital"
4. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
5. First human clone is near
6. First Artificial Heart patient has Major setback
7. First global SARS meet opens
8. Launch Of India’s First Virology Course At Pun
9. FDA approves first pocket-sized EKG machine
10. First head-to-head trials of once weekly Fosamax and Actonel therapies
11. WHO Declares Vietnam First Country to Control SARS
Post Your Comments:
(Date:6/26/2016)... , ... June 27, 2016 , ... Quality metrics are ... in many ways they remain in the eye of the beholder, according to experts ... publication of The American Journal of Managed Care. For the full issue, click ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... , ... June 25, 2016 , ... ... policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at ... on several important health care topics including advance care planning, healthcare costs and ...
(Date:6/25/2016)... ... ... "With 30 hand-drawn hand gesture animations, FCPX users can easily customize each ... Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures into hand ... select a ProHand generator and drag it above media or text in the Final ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: